Protox Therapeutics Adds Rohm, Sobti to Board

Publicly traded Protox Therapeutics Inc. has added William Rohn and Amit Sobti to its board of directors. Rohn is a former chief operating officer for biotech company Biogen-Idec. Sobti is a principal with Warburg Pincus, where he focuses on investments in healthcare. He worked previously at Rhone Capital, a mid-market private equity firm.

PeopleNorth AmericaUSBriefs